Advances in Intraarterial Chemotherapy Delivery Strategies and Blood-Brain Barrier Disruption
Authors:
- 25 March 2022
- journal article
- research article
- Published by Elsevier in Neurosurgery Clinics of North America
- Vol. 33 (2) , 219-223
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant gliomaJournal of Neurosurgery, 2011
- Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- A Phase I/II Study of Direct Intraarterial (Ophthalmic Artery) Chemotherapy with Melphalan for Intraocular RetinoblastomaOphthalmology, 2008
- Intraarterial chemotherapy and osmotic blood‐brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous systemCancer, 2007
- Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in the treatment of cerebral metastasisCancer, 2007
- Benign Adult Brain Tumors: An Evidence-Based Medicine Review2006
- Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood‐brain‐barrier disruptionPediatric Blood & Cancer, 2005
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005
- Chemotherapeutic Agent Permeability to Normal Brain and Delivery to Avian Sarcoma Virus-induced Brain Tumors in the Rodent: Observations on Problems of Drug DeliveryNeurosurgery, 1984
- First-Pass EliminationClinical Pharmacokinetics, 1984